Journal of Medicinal Chemistry follows a rigorous and transparent editorial policy designed to maintain the highest standards of scientific integrity, scholarly excellence, and ethical publishing practices. Our policies ensure that every manuscript submitted to the journal undergoes fair evaluation, constructive peer review, and ethical consideration before publication.

1. Commitment to Scientific Quality

• All submissions are evaluated solely on the basis of scientific originality, clarity of presentation, methodological rigor, and relevance to the field of medicinal chemistry.
• The journal does not discriminate on the grounds of nationality, institutional affiliation, gender, or academic seniority of the authors.

2. Editorial Independence

• Decisions regarding acceptance or rejection of manuscripts are made exclusively by the editorial board, based on peer reviewers’ recommendations and the Editor-in-Chief’s assessment.
• Commercial interests, sponsorship, or advertising partnerships do not influence editorial decisions.

3. Peer Review Integrity

• A double-blind peer review process is employed to minimize bias.
• Reviewers are selected for their subject expertise, impartiality, and ability to provide constructive feedback.
• Editors ensure that reviews are respectful, transparent, and focused on improving the quality of the work.

4. Ethical Publishing Standards

• Authors must adhere to established guidelines for research integrity, including proper citations, avoidance of plagiarism, and transparent data reporting.
• Studies involving human or animal subjects must include appropriate ethical approval and informed consent documentation.
• Any suspected misconduct (plagiarism, fabrication, duplicate submission, or authorship disputes) will be investigated according to international best practices (COPE guidelines).

5. Conflict of Interest Declaration

• Authors, reviewers, and editors are required to disclose any potential conflicts of interest that may influence the objectivity of the work.
• The journal maintains transparency in publishing by including conflict of interest statements with published articles when relevant.

6. Authorship and Contributions

• Only individuals who have made significant contributions to the conception, design, execution, or interpretation of the study should be listed as authors.
• The corresponding author must ensure that all co-authors have approved the final version of the manuscript prior to submission.

7. Transparency in Editorial Decisions

• Authors receive clear communication regarding the outcome of their submissions, including detailed reasons for acceptance, revision, or rejection.
• Appeals are considered when authors believe their work has not been fairly evaluated, provided sufficient justification is given.

8. Open Access and Licensing

• To maximize visibility and impact, the journal publishes all content under an open access model.
• Authors retain copyright, while granting the journal the right to distribute their work under a permissive license (details available in the “Open Access Policy”).

9. Post-Publication Practices

• The journal supports post-publication discussion and correction of scientific records.
• Errata, corrigenda, or retractions will be issued when necessary, following transparent procedures.

10. Commitment to Continuous Improvement

• The editorial board regularly reviews policies to adapt to emerging challenges in scientific publishing, including data transparency, reproducibility, and evolving ethical concerns.